Enhanced Antitumor Effect of Coincident Intravesical Gemcitabine Plus BCG Therapy in an Orthotopic Bladder Cancer Model

References

Page 1

	Year	Citations
Cancer Statistics, 2008 Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward, CA A Cancer Journal for Clinicians Cancer StatisticsEpidemiologyCancer EpidemiologyMedicineEpidemiology Of Cancer	2008	10.2K
The Effect of Intravesical Mitomycin C on Recurrence of Newly Diagnosed Superficial Bladder Cancer: A Further Report with 7 Years of Followup David A. Tolley, Mahesh Parmar, Kenneth M. Grigor, The Journal of Urology	1996	324
Gemcitabine: a promising new agent in the treatment of advanced urothelial cancer. Malcolm J. Moore, Ian F. Tannock, D. Scott Ernst, Journal of Clinical Oncology	1997	272
Phase I Trial of Intravesical Gemcitabine in Bacillus Calmette-Guérin–Refractory Transitional-Cell Carcinoma of the Bladder Guido Dalbagni, Paul Russo, Joel Sheinfeld, Journal of Clinical Oncology	2002	259
Gemcitabine exerts a selective effect on the humoral immune response: implications for combination chemo-immunotherapy. Anna K. Nowak, Bruce Robinson, Richard Lake PubMed Combination Chemo-immunotherapyHumoral Immune ResponseHumoral ResponseImmunologyImmunologic Mechanism	2002	241
A Combination of Chemoimmunotherapies Can Efficiently Break Self-Tolerance and Induce Antitumor Immunity in a Tolerogenic Murine Tumor Model Hyun‐Jeong Ko, Yeon‐Jeong Kim, Yun-Sun Kim, Cancer Research	2007	202
Apparent Failure of Current Intravesical Chemotherapy Prophylaxis to Influence the Long-Term Course of Superficial Transitional Cell Carcinoma of the Bladder Donald L. Lamm, Dale R. Riggs, Christian L. Traynelis, The Journal of Urology	1995	189
Original Articles: Bladder Cancer: A Randomized Study of Intravesical Mitomycin C, Bacillus Calmette-Guerin Tice and Bacillus Calmette-Guerin RIVM Treatment in pTa-pT1 Papillary Carcinoma and Carcinoma in Situ of the Bladder P. D. J. Vegt, J. Alfred Witjes, Wim P.J. Witjes, The Journal of Urology Surgical OncologyMitomycin CPathologyReconstructive UrologyUrogenital Radiology	1995	123
Intravesical gemcitabine therapy for superficial transitional cell carcinoma: Results of a Phase II prospective multicenter study Riccardo Bartoletti, Tommaso Cai, Mauro Gacci, Urology Surgical OncologyIntravesical Gemcitabine TherapyGenitourinary CancerMedicineBrachytherapy	2005	104
Intravesical Gemcitabine Therapy for Superficial Transitional Cell Carcinoma of the Bladder: A Phase I and Pharmacokinetic Study Menachem Laufer, Sakkaraiappan Ramalingam, Mark Schoenberg, Journal of Clinical Oncology	2003	101

Page 1